• 1
    Rattner JB, Fritzler MJ. Centriole and centrosome autoantibodies. In: PeterJB, ShoenfeldY, eds. Autoantibodies. Amsterdam: Elsevier Science BV, 1996, pp. 153160.
  • 2
    Gavanescu D, Vasquez-Abad McCauley J, Senécal J-L, Doxsey S. Centrosome proteins: a major class of autoantigens in scleroderma. J Clin Immunol 1999; 19: 16671.
  • 3
    Balczon R. Autoantibodies as probes in cell and molecular biology. Proc Soc Exp Biol Med 1993; 204: 13854.
  • 4
    Mu FT, Callaghan JM, Steele-Mortimer HS et al. EEA1, an early endosomal protein. J Biol Chem 1995; 270: 1350311.
  • 5
    Selak S, Schoenroth L, Senécal J-L, Fritzler MJ. Early endosome antigen 1: an autoantigen associated with neurological diseases. J Invest Med 1999; 47: 3118.
  • 6
    Kain R, Matsui K, Exner M et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 1995; 181: 58597.
  • 7
    Chan EKL, Fritzler MJ. Autoantibodies to Golgi apparatus antigens. In: ConradK, HumbelR-L, MeurerM, ShoenfeldY, TanEM, eds. Pathogenic and diagnostic relevance of autoantibodies. Proceedings of the 4th Dresden Symposium on Autoantibodies. Scottsdale, AZ: Pabst Scientific Publishers, 1998, pp. 85100.
  • 8
    Chan EKL, Fritzler MJ. Golgins: coiled-coil-rich proteins associated with the Golgi complex. Electronic J Biotechnol 1998; 1.
  • 9
    Fritzler MJ, Manns MP. Anti-mitochondrial antibodies. Clin Appl Immunol Rev 2002; 3: 87113.
  • 10
    Eystathioy T, Chan EKL, Yang Z et al. Clinical and serological associations of autoantibodies to a novel cytoplasmic autoantigen, GW182 and GW bodies. J Mol Med 2003; 81: 8118.
  • 11
    Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthritis Rheum 1995; 24: 32358.
  • 12
    Fritzler MJ. Clinical relevance of autoantibodies in systemic rheumatic diseases. Mol Biol Rep 1996; 23: 13345.
  • 13
    Stinton LM, Eystathioy T, Selak S, Chan EKL, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, golgi complex, proteasomes, assemblyosomes, exosomes and GW bodies. Clin Immunol 2004; 110: 3044.
  • 14
    Konstantinov K, Foisner R, Byrd D et al. Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol 1995; 74: 8999.
  • 15
    Lin F, Noyer CMYeQ, Courvalin JC, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 1996; 23: 5761.
  • 16
    Konstantinov K, Von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996; 98: 188896.
  • 17
    Lin F, Blake DL, Callebaut I et al. MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem 2000; 275: 48407.
  • 18
    Nesher G, Margalit R, Ashkenazi YJ. Anti-nuclear envelope antibodies: clinical associations. Semin Arthritis Rheum 2001; 30: 31320.
  • 19
    Miyachi K, Hankins RW, Matsushima H et al. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 2003; 20: 24754.
  • 20
    Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 2003; 37: 31529.
  • 21
    Salina D, Bodoor K, Enarson P, Raharjo WH, Burke B. Nuclear envelope dynamics. Biochem Cell Biol 2001; 79: 53342.
  • 22
    Zhen YY, Libotte T, Munck M, Noegel AA, Korenbaum E. NUANCE, a giant protein connecting the nucleus and actin cytoskeleton. J Cell Sci 2002; 115: 320722.
  • 23
    Dreger M, Bengtsson L, Schoneberg T, Otto H, Hucho F. Nuclear envelope proteomics: novel integral membrane proteins of the inner nuclear membrane. Proc Natl Acad Sci USA 2001; 98: 119438.
  • 24
    Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002; 158: 91527.
  • 25
    Cordes VC, Reidenbach S, Rackwitz HR, Franke WW. Identification of protein p270/Tpr as a constitutive component of the nuclear pore complex-attached intranuclear filaments. J Cell Biol 1997; 136: 51529.
  • 26
    Bangs P, Burke B, Powers C, Craig R, Purohit A, Doxsey S. Functional analysis of Tpr: identification of nuclear pore complex association and nuclear localization domains and a role in mRNA export. J Cell Biol 1998; 143: 180112.
  • 27
    Frosst P, Guan T, Subauste C, Hahn K, Gerace L. Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol 2002; 156: 61730.
  • 28
    Shibata S, Matsuoka Y, Yoneda Y. Nucleocytoplasmic transport of proteins and poly (A) + RNA in reconstituted Tpr-less nuclei in living mammalian cells. Genes Cells 2002; 7: 42134.
  • 29
    Fritzler MJ. Autoantibody testing: procedures and significance in systemic rheumatic diseases. Meth Achiv Exp Pathol 1986; 12: 22460.
  • 30
    Fritzler MJ, Lung C-C, Hamel JC, Griffith K, Chan EKL. Molecular characterization of golgin-245: a novel Golgi complex protein containing a granin signature. J Biol Chem 1995; 270: 312628.
  • 31
    Griffith KJ, Chan EKL, Hamel JC, Miyachi K, Fritzler MJ. Molecular characterization of a novel 97 kDa Golgi complex autoantigen recognized by autoimmune antibodies from patients with Sjögren's syndrome. Arthritis Rheum 1997; 40: 1693702.
  • 32
    Bender TP. Isolation of nuclei by sucrose gradient centrifugation. In: AusubelFM, BrentR, KingstonRE et al., eds. Current protocols in molecular biology. New York: Wiley Interscience, 1996, pp. 10·610·11.
  • 33
    Mack GJ, Rees J, Sandblom O, Balczon R, Fritzler MJ, Rattner JB. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome. Arthritis Rheum 1998; 41: 5518.
  • 34
    Eystathioy T, Chan EKL, Mahler M, Luft LM, Fritzler ML, Fritzler MJ. A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182. Hybridoma Hybridomics 2003; 22: 7986.
  • 35
    Eystathioy T, Chan EKL, Tenenbaum SA, Keene JD, Griffith KJ, Fritzler MJ. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Cell Biol 2002; 13: 133851.
  • 36
    Austen B, Frears ER, Davies H. The use of Seldi Protein Chip™ arrays to monitor production of Alzheimer's β-amyloid in transfected cells. J Peptide Sci 2000; 6: 45969.
  • 37
    Courvalin J-C, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990; 172: 9617.
  • 38
    Konstantinov K. Nuclear envelope protein autoantibodies. In: PeterJB, ShoenfeldY, eds. Autoantibodies. Amsterdam: Elsevier Science BV, 1996, pp. 5616.
  • 39
    Zhang Q, Skepper JN, Yang F et al. Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci 2001; 114: 448598.
  • 40
    Byrd DA, Sweet DJ, Pante N et al. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol 1994; 127: 151526.
  • 41
    Greber UF, Senior A, Gerace L. A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J 1990; 9: 1495502.
  • 42
    Nozawa K, Fritzler MJ, Von Mühlen CA, Chan EKL. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res Ther 2004; 6: R95R102.
  • 43
    Courvalin J-C, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990; 86: 27985.
  • 44
    Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetyl glucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol Biol Rep 1996; 23: 22734.
  • 45
    Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001; 134: 86881.
  • 46
    Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in ‘healthy’ individuals. Arthritis Rheum 1997; 40: 160111.
  • 47
    Fritzler MJ, Wiik A, Fritzler ML, Barr SG. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003; 5: 192201.
  • 48
    Invernizzi P, Podda M, Battezzati PM et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001; 34: 36672.
  • 49
    Kraemer DM, Kraus MR, Kneitz C, Tony HP. Nucleoporin p62 antibodies in a case of mixed connective tissue disease. Clin Diagn Lab Immunol 2003; 10: 32931.
  • 50
    Wilken N, Senecal JL, Scheer U, Dabauvalle MC. Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex. Eur J Cell Biol 1995; 68: 2119.
  • 51
    Kraemer D, Wozniak RW, Blobel G, Radu A. The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 151923.
  • 52
    Pante N, Aebi U. Toward the molecular details of the nuclear pore complex. J Struct Biol 1994; 113: 17989.
  • 53
    Bastos R, Ribas DP, Enarson M, Bodoor K, Burke B. Nup84, a novel nucleoporin that is associated with CAN/Nup214 on the cytoplasmic face of the nuclear pore complex. J Cell Biol 1997; 137: 9891000.
  • 54
    Le Rouzic E, Mousnier A, Rustum C et al. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J Biol Chem 2002; 277: 450918.
  • 55
    Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci USA 2003; 100: 58237.
  • 56
    Walther TC, Pickersgill HS, Cordes VC et al. The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J Cell Biol 2002; 158: 6377.
  • 57
    Soderqvist H, Hallberg E. The large C-terminal region of the integral pore membrane protein, POM121, is facing the nuclear pore complex. Eur J Cell Biol 1994; 64: 18691.
  • 58
    Grote M, Kubitscheck U, Reichelt R, Peters R. Mapping of nucleoporins to the center of the nuclear pore complex by post-embedding immunogold electron microscopy. J Cell Sci 1995; 108: 296372.
  • 59
    Schirmer EC, Florens L, Guan T, Yates JR III, Gerace L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 2003; 301: 13802.
  • 60
    Worman HJ, Feng L, Mamiya N. Molecular biology and the diagnosis and treatment of liver diseases. World J Gastroenterol 1998; 4: 18591.
  • 61
    Ostlund C, Worman HJ. Nuclear envelope proteins and neuromuscular diseases. Muscle Nerve 2003; 27: 393406.
  • 62
    Fritzler MJ. New technologies in the detection of autoantibodies. In: ConradK, FritzlerMJ, MeurerM, SackU, ShoenfeldY, eds. Autoantigens, autoantibodies, autoimmunity. Lengerich: Pabst Scientific Publishers, 2002.